Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ultra-rare disorder that causes progressive multisystem disease and neurologic decline.
Joseph Muenzer, MD, PhD, the Director of the Muenzer MPS Research and Treatment Center and the Bryson Distinguished Professor in Pediatric Genetics at the UNC School of Medicine, served as the study’s lead investigator for Denali Therapeutics’ clinical trial.
➡️ Read the full press release: https://news.unchealthcare.org/2026/01/renowned-unc-pediatric-biochemical-geneticist-leads-first-study-on-a-novel-treatment-for-hunter-syndrome/